Rick J Jansen

Rick J Jansen is a Researcher in Biostatistics at the University of Minnesota, with significant contributions across multiple medical research domains. His work spans the Office of Academic Clinical Affairs, Genetics, and Mechanisms of Cancer research areas, reflecting a multidisciplinary approach to biomedical investigation. Dr. Jansen maintains an active research profile with 36 total research outputs including 31 articles, 4 review articles, and 1 book chapter.

His primary research interests center on the application of advanced statistical methods to complex biological systems. Key focus areas include cancer epidemiology (particularly pancreatic cancer and triple-negative breast cancer), microbiome-host interactions across various environments including spaceflight, computational immunology, and public health applications of vaccinology. His work frequently bridges clinical medicine with quantitative analysis to identify biomarkers, assess disease risk, and develop predictive models for treatment response.

Dr. Jansen's publication record demonstrates consistent productivity with research outputs spanning from 2011 to 2025. His recent work shows increasing emphasis on translational research with direct clinical applications, particularly in cancer disparities, microbiome-related disease mechanisms, and vaccine effectiveness. The interdisciplinary nature of his research is evident in collaborations across multiple institutions and funding sources.

As Principal Investigator, Dr. Jansen currently leads significant research initiatives including:

• Early detection of cancer disparity and treatment resistance in TNBC (2024-2027)
• Developing A Prognostic Companion Molecular Test for Triple-Negative Breast Cancer (2024-2025)

He also serves as Co-Investigator on important projects such as:

• Longitudinal characterization of the role of the mucosal virome and microbiome in juvenile idiopathic arthritis flares (2024-2026)
• Longitudinal Surveillance of Congenital CMV Infections Identified by Newborn Screening (2023-2027)

Dr. Jansen's research has attracted attention across multiple platforms, with his work being picked up by news outlets, blogged about, and shared across social media platforms including X (Twitter) and Bluesky. His publications have accumulated Scopus citations and have been read by researchers on platforms like Mendeley, indicating growing recognition in his fields of expertise.